PRISYM ID, a leading provider of data-led label and artwork management solutions, will host its first-ever virtual stand at a prestigious industry event which has gone digital this year in response to the COVID-19 pandemic.
PRISYM ID will be setting up shop at the Clinical Trial Supply Forum on August 25-26, where visitors to the company’s virtual stand will be able to browse its extensive portfolio, watch product demonstrations and videos and obtain expert help and advice.
Of particular interest to visitors will be the PRISYM 360 SaaS clinical trials labeling solution - a pre-validated system, which removes a lot of the time associated with implementing and validating a labeling system, as well as the cost and risk.
To support clinical research organizations’ responses to the COVID-19 crisis and help them meet the urgent demand for treatments, PRISYM ID has been offering instant access to this cloud-based, ready to use version of its PRISYM 360 platform.
This is not only PRISYM ID’s first virtual stand, it is also the first time that the company has exhibited at a major industry event this year, owing to the constraints of the coronavirus pandemic.
Warren Stacey, SVP of Sales at PRISYM ID, commented: “The coronavirus pandemic has brought huge uncertainty to the business world, particularly when it comes to conference attendance. However, companies must adapt to these difficult circumstances and find new ways to engage with their customers at such events.
“We’re really looking forward to welcoming visitors to our first-ever virtual stand. We’ve put a huge amount of effort into making it an engaging and interactive experience that will take visitors on a journey through our extensive product portfolio. We look forward to meeting many new and existing customers over the two-day event and assisting them with their clinical trial labeling issues.”